Truvada Archives -

Market Access/ News/ News/ News/ Patients

Gilead wins court order against fraudsters targeting HIV programme

Phil Taylor Descovy, fraud, Gilead Sciences, HIV, pre-exposure prophylaxis, Truvada 0 Comment

Gilead has won a crucial court order in a wide-ranging lawsuit against a network of clinics, prescribers, medical

Gilead wins court order against fraudsters targeting HIV programme

https://pharmaphorum.com/news/gilead-wins-court-order-against-fraudsters-targeting-hiv-programme/

Market Access/ News/ News

FDA okays ViiV’s Apretude as first injectable for HIV PrEP

Phil Taylor Apretude, cabotegravir, Descovy, Gilead Sciences, GlaxoSmithKline, HIV, PrEP, Truvada, ViiV Healthcare 0 Comment

GlaxoSmithKline’ majority-owned HIV unit ViiV has scored a key FDA approval, getting approval for its long-acting drug cabotegravir

FDA okays ViiV’s Apretude as first injectable for HIV PrEP

https://pharmaphorum.com/news/fda-okays-viivs-apretude-as-first-injectable-for-hiv-prep/

Digital/ News/ News

Digital pill tracks HIV PrEP adherence with 98% accuracy

Phil Taylor digital, digital health, digital pill, Gilead Sciences, HIV, PrEP, Truvada 0 Comment

A digital pill that records when it is taken has been shown to be highly effective at helping

Digital pill tracks HIV PrEP adherence with 98% accuracy

https://pharmaphorum.com/news/digital-pill-tracks-hiv-prep-adherence-with-98-accuracy/

News/ News/ Sales and Marketing

Humira tops list of drugs with unwarranted US price hikes

Phil Taylor AbbVie, Amgen, Biogen, cialis, drug prices, Eli Lilly, Gilead Sciences, Humira, ICER, lyrica, Neulasta, Rituxan, Roche, Tecfidera, Truvada 0 Comment

AbbVie’s Humira heads a list of seven medicines that collectively contributed to a $5.1 billion increase in US

Humira tops list of drugs with unwarranted US price hikes

https://pharmaphorum.com/news/humira-tops-list-of-drugs-with-unwarranted-us-price-hikes/

Market Access/ News/ News

Gilead will challenge US government patent on PrEP drug Truvada

Phil Taylor Gilead Sciences, HIV, patent litigation, PrEP, Truvada 0 Comment

Gilead Sciences has said it plans to challenge patents held by the US government on the use of

Gilead will challenge US government patent on PrEP drug Truvada

https://pharmaphorum.com/news/gilead-will-challenge-us-government-patent-on-prep-drug-truvada/

News/ News/ R&D

Gilead files Truvada follow-up Descovy for PrEP

Phil Taylor Descovy, Gilead, PrEP therapy, Truvada 0 Comment

Gilead Sciences has filed Descovy, its successor to HIV pre-exposure prophylaxis (PrEP) therapy Truvada, in the US, spending

Gilead files Truvada follow-up Descovy for PrEP

https://pharmaphorum.com/news/gilead-files-truvada-follow-up-descovy-for-prep/

News/ UK & Europe

Charity raises funds for legal fight over HIV drug

Richard Staines AIDS, Gilead, HIV, pre-exposure prophylaxis, Truvada 0 Comment

National AIDS Trust continues legal battle over Truvada.

Charity raises funds for legal fight over HIV drug

https://pharmaphorum.com/news/charity-crowdfunding-hiv-drug-fight/

News/ UK & Europe

EU approves Gilead’s Truvada for HIV prevention

Richard Staines Gilead, HIV, PrEP, Truvada 0 Comment

But there are funding problems in UK, Australia and Canada.

EU approves Gilead’s Truvada for HIV prevention

https://pharmaphorum.com/news/eu-approves-gileads-truvada-hiv-prevention/

News/ Pharma Market Access/ Sales and Marketing/ UK & Europe

Gilead’s Truvada backed in EU for HIV prevention

Richard Staines HIV, NHS, PrEP, Truvada 0 Comment

CHMP backs HIV pre-exposure prophylaxis use.

Gilead’s Truvada backed in EU for HIV prevention

https://pharmaphorum.com/news/gileads-truvada-backed-eu-hiv-prevention/

Trending

Truvada

Login